Functional genomics studied by proteomics

被引:38
作者
Honoré, B
Ostergaard, M
Vorum, H
机构
[1] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1002/bies.20075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human genome contains about 30,000 genes, each creating several transcripts per gene. Transcript structures and expression are studied by high-throughput transcriptomic techniques using microarrays. Generally, transcripts are not directly operating molecules, but are translated into functional proteins, post-translationally modified by proteolysis, glycosylation, phosphorylation, etc., sometimes with great functional impact. Proteins need to be analyzed by proteomic techniques, less suited for high-throughput. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), separating thousands of proteins has developed slowly over the past quarter of a century. This technique is now quite reproducible and suitable for differential proteomics, comparing normal and diseased cells/tissues revealing differentially regulated proteins. 2D-PAGE is combined with protein-identification methods, currently mass spectrometry (MS), which has been significantly improved over the last decade. Other proteomic techniques studying protein-protein interactions are now either established or still being developed, such as peptide or protein arrays, phage display, and the yeast two-hybrid system. The strengths and weaknesses of these techniques are discussed. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:901 / 915
页数:15
相关论文
共 130 条
[41]  
2-9
[42]   SPECIFIC ISOLATION OF O-LINKED N-ACETYLGLUCOSAMINE GLYCOPEPTIDES FROM COMPLEX-MIXTURES [J].
HAYES, BK ;
GREIS, KD ;
HART, GW .
ANALYTICAL BIOCHEMISTRY, 1995, 228 (01) :115-122
[43]   Methods and reagents - False positives from the yeast two-hybrid system [J].
Hengen, PN .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (01) :33-34
[44]   Microarrayed allergen molecules:: diagnostic gatekeepers for allergy treatment [J].
Hiller, R ;
Laffer, S ;
Harwanegg, C ;
Huber, M ;
Schmidt, WM ;
Twardosz, A ;
Barletta, B ;
Becker, WM ;
Blaser, K ;
Breiteneder, H ;
Chapman, M ;
Crameri, R ;
Duchêne, M ;
Ferreira, F ;
Fiebig, H ;
Hoffmann-Sommergruber, K ;
King, TP ;
Kleber-Janke, T ;
Kurup, VP ;
Lehrer, SB ;
Lidholm, J ;
Müller, U ;
Pini, C ;
Reese, G ;
Scheiner, O ;
Scheynius, A ;
Shen, HD ;
Spitzauer, S ;
Suck, R ;
Swoboda, I ;
Thomas, W ;
Tinghino, R ;
Van Hage-Hamsten, M ;
Virtanen, T ;
Kraft, D ;
Müller, MW ;
Valenta, R .
FASEB JOURNAL, 2002, 16 (01) :414-+
[45]   The use of recombinant antibodies in proteomics [J].
Holt, LJ ;
Enever, C ;
de Wildt, RMT ;
Tomlinson, IM .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (05) :445-449
[46]   Changes in protein expression in p53 deleted spontaneous thymic lymphomas [J].
Honoré, B ;
Vorum, H ;
Pedersen, AE ;
Buus, S ;
Claësson, MH .
EXPERIMENTAL CELL RESEARCH, 2004, 295 (01) :91-101
[47]  
Honore B, 2001, Expert Rev Mol Diagn, V1, P265, DOI 10.1586/14737159.1.3.265
[48]  
HONORE B, 2003, NATURE ENCY HUMAN GE, P579
[49]   Antibody phage display technology and its applications [J].
Hoogenboom, HR ;
de Bruine, AP ;
Hufton, SE ;
Hoet, RM ;
Arends, JW ;
Roovers, RC .
IMMUNOTECHNOLOGY, 1998, 4 (01) :1-20
[50]  
Hoving S, 2000, ELECTROPHORESIS, V21, P2617, DOI 10.1002/1522-2683(20000701)21:13<2617::AID-ELPS2617>3.3.CO